URGN 股價走勢圖
URGN 股票價格預測
Urogen Pharma Ltd
$33.57
2.31%
$0.75
收盤價：Jun 18, 16:00:00 GMT-4
$33.57
0%
$0
盤前：Jun 22, 07:00:57 GMT-4
返回
Urogen Pharma Ltd (URGN) 股票價格預測
關鍵數據
前收市價
$32.81
開盤價
$33.37
當日範圍
$32.21 - $33.79
52週區間
$12.61 - $33.57
交易量
847.0K
平均成交量
810.2K
股息收益率
--
每股盈餘 (TTM)
-2.75
市值
$1.6B
什麼是 URGN？
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. The firm is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).
